Gfinity, Arix Bioscience and Meastrano
If you find this podcast useful please give it a rating and review on iTunes by clicking here
Do you want to get instant company alerts to the front screen of your smartphone? Download the Vox Markets app here: www.VoxMarkets.co.uk/app
On today's Vox Markets Podcast: Gfinity, Arix Bioscience and Meastrano
Graham Wallace Chief Executive Officer of Gfinity (GFIN) discusses their final results and their progress in the world of esports.
Gfinity is a leading international esports business. Created by gamers for the world’s 2.2bn gamers, Gfinity has a unique understanding of this fast-growing global community. It uses this expertise to provide both advisory services and to design, develop and deliver unparalleled experiences and winning strategies for game publishers, sports rights holders, commercial partners and media companies.
Jonathan Tobin, Investment Director of Arix Bioscience (ARIX) discusses one of their portfolio companies Artios Pharma which has announced the expansion of its DNA Damage Response pipeline with a new asset.
Arix Bioscience plc is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting edge advances in life sciences. We collaborate with exceptional entrepreneurs and provide the capital, expertise and global networks to help accelerate their ideas into important new treatments for patients. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors.
(Interview starts at 29 minutes 23 seconds)
Andrew Pearson, CEO of Maestrano (MNO) talks about the acquisition of Airsight an engineering surveying services company that uses AI enabled digital recording devices.
Maestrano develops and deploys a patented cloud-based Platform as a Service that serves the needs of Small to Medium Businesses (SMBs) and large Enterprises to access real time, automated management data efficiently on an integrated platform. This technology is called Master Data Management (MDM).
(Interview starts at 27 minutes 51 seconds)
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.